Search research articles
Contact Us
Filters
Showing results (111-120 of 137) with videos related to
Page
of 14
Sort By:
International Journal of Cancer
|
September 15, 1994
PEG-IL-2 therapy of advanced cancer in the guinea pig. Impact of the primary tumor and beneficial effect of cyclophosphamide
L T Balemans, P A Steerenberg, F J Koppenhagen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 1, 1992
A phase II trial of 10-ethyl-10-deaza-aminopterin, a novel antifolate, in patients with advanced and/or recurrent squamous cell carcinoma of the head and neck. The EORTC Head and Neck Cancer Cooperative Group
J H Schornagel, J Verweij, P H de Mulder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 1994
Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head and Neck Cancer Cooperative Group
M Clavel, J B Vermorken, F Cognetti, et al.
Gut
|
August 1, 1990
Pancreatic carcinoma with polyarthritis, fat necrosis, and high serum lipase and trypsin activity
R J van Klaveren, P H de Mulder, A M Boerbooms, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1995
Randomized phase III trial of edatrexate versus methotrexate in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck: a European Organization for Research and Treatment of Cancer Head and Neck Cancer Cooperative Group study
J H Schornagel, J Verweij, P H de Mulder, et al.
British Journal of Cancer
|
January 1, 1997
Phase IB study of doxorubicin in combination with the multidrug resistance reversing agent S9788 in advanced colorectal and renal cell cancer
C J Punt, E E Voest, E Tueni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1996
Analysis of cumulative probabilities shows that the efficacy of 5HT3 antagonist prophylaxis is not maintained
R de Wit, P I Schmitz, J Verweij, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 1, 1994
Intratumoral PEG-interleukin-2 therapy in patients with locoregionally recurrent head and neck squamous-cell carcinoma
V Mattijssen, P H De Mulder, A De Graeff, et al.
European Journal of Cancer & Clinical Oncology
|
August 1, 1989
Mitozolomide in advanced renal cancer. A phase II study in previously untreated patients from the EORTC Genito-Urinary Tract Cancer Cooperative Group
A T van Oosterom, G Stoter, A V Bono, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 1996
Phase II study on mitoxantrone in adenoid cystic carcinomas of the head and neck. EORTC Head and Neck Cancer Cooperative Group
J Verweij, P H de Mulder, A de Graeff, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 137) with videos related to
Sort By:
Page
of 14
International Journal of Cancer
|
September 15, 1994
PEG-IL-2 therapy of advanced cancer in the guinea pig. Impact of the primary tumor and beneficial effect of cyclophosphamide
L T Balemans, P A Steerenberg, F J Koppenhagen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 1, 1992
A phase II trial of 10-ethyl-10-deaza-aminopterin, a novel antifolate, in patients with advanced and/or recurrent squamous cell carcinoma of the head and neck. The EORTC Head and Neck Cancer Cooperative Group
J H Schornagel, J Verweij, P H de Mulder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 1994
Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head and Neck Cancer Cooperative Group
M Clavel, J B Vermorken, F Cognetti, et al.
Gut
|
August 1, 1990
Pancreatic carcinoma with polyarthritis, fat necrosis, and high serum lipase and trypsin activity
R J van Klaveren, P H de Mulder, A M Boerbooms, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1995
Randomized phase III trial of edatrexate versus methotrexate in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck: a European Organization for Research and Treatment of Cancer Head and Neck Cancer Cooperative Group study
J H Schornagel, J Verweij, P H de Mulder, et al.
British Journal of Cancer
|
January 1, 1997
Phase IB study of doxorubicin in combination with the multidrug resistance reversing agent S9788 in advanced colorectal and renal cell cancer
C J Punt, E E Voest, E Tueni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1996
Analysis of cumulative probabilities shows that the efficacy of 5HT3 antagonist prophylaxis is not maintained
R de Wit, P I Schmitz, J Verweij, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 1, 1994
Intratumoral PEG-interleukin-2 therapy in patients with locoregionally recurrent head and neck squamous-cell carcinoma
V Mattijssen, P H De Mulder, A De Graeff, et al.
European Journal of Cancer & Clinical Oncology
|
August 1, 1989
Mitozolomide in advanced renal cancer. A phase II study in previously untreated patients from the EORTC Genito-Urinary Tract Cancer Cooperative Group
A T van Oosterom, G Stoter, A V Bono, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 1996
Phase II study on mitoxantrone in adenoid cystic carcinomas of the head and neck. EORTC Head and Neck Cancer Cooperative Group
J Verweij, P H de Mulder, A de Graeff, et al.
Page
of 14